{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:23:27Z","timestamp":1785432207951,"version":"3.56.0"},"reference-count":143,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Respir Res Clin Pract"],"published-print":{"date-parts":[[2026,2,10]]},"abstract":"<jats:p>Objective: Critically ill patients with respiratory disease often experience impaired airway\nclearance, which contributes to adverse clinical outcomes. N-acetylcysteine (NAC) has\nmucolytic and antioxidant properties, and may have therapeutic potential in this setting.\nThis study evaluated the impact of NAC on clinical outcomes in ICU patients with\nunderlying respiratory disease. Methods: A systematic literature search was conducted\nin PubMed\/MEDLINE, Embase, the Cochrane Central Register of Controlled Trials,\nScopus, and Web of Science from January of 2000 to July of 2025 in order to identify\nrandomized controlled trials evaluating NAC in ICU patients with respiratory conditions.\nPrimary outcomes included hospital mortality, duration of mechanical ventilation, ICU\nlength of stay (LOS), and hospital LOS. Data were synthesized using fixed- or randomeffects models based on heterogeneity. Subgroup analyses were performed based on\nthe route of NAC administration. Results: Five randomized controlled trials comprising\n340 patients were included. Hospital mortality was 44.76% in the NAC group and\n47.61% in the control group (OR = 0.87; 95% CI: 0.49-1.53). No significant differences\nwere observed in ventilation duration (mean difference [MD] = 0.79 days; 95% CI: \u22122.87\nto 4.44) or ICU LOS (MD = 0.21 days; 95% CI: \u22123.75 to 4.17). However, NAC was\nassociated with a shorter hospital stay (MD = \u22123.84 days; 95% CI: \u22127.44 to \u22120.24).\nSubgroup analysis suggested variability in mortality outcomes based on administration\nroute. Conclusions: NAC may reduce hospital LOS in critically ill patients with respiratory\ndisease, although its effects on mortality and ventilation duration remain inconclusive.\nThese findings may inform future research, particularly in patients with post-infectious\nlung damage such as that seen in COVID-19 or tuberculosis.<\/jats:p>","DOI":"10.36416\/1806-3756\/e20250438","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T19:55:02Z","timestamp":1774295702000},"page":"e20250438","source":"Crossref","is-referenced-by-count":0,"title":["Clinical effects of N-acetylcysteine in ICU patients with respiratory disease: a systematic review and meta-analysis"],"prefix":"10.36416","author":[{"given":"Mehrnaz","family":"Amiri1","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/034m2b326","id-type":"ROR","asserted-by":"publisher"}],"name":"Shahid Beheshti University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdis","family":"Cheraghi1","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01c4pz451","id-type":"ROR","asserted-by":"publisher"}],"name":"Tehran University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farima","family":"Khalili1","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01c4pz451","id-type":"ROR","asserted-by":"publisher"}],"name":"Tehran University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"D\u2019Ambrosio2","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00v0nyw36","id-type":"ROR","asserted-by":"publisher"}],"name":"Pioneers Research and Consulting Group (Switzerland)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella","family":"Centis3","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00mc77d93","id-type":"ROR","asserted-by":"publisher"}],"name":"Istituti Clinici Scientifici Maugeri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh","family":"Tuan Dinh-Xuan4","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05f82e368","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris Cit\u00e9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwanath","family":"Venketaraman5","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05167c961","id-type":"ROR","asserted-by":"publisher"}],"name":"Western University of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Javad Nasiri1","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/034m2b326","id-type":"ROR","asserted-by":"publisher"}],"name":"Shahid Beheshti University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Battista Migliori3","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00mc77d93","id-type":"ROR","asserted-by":"publisher"}],"name":"Istituti Clinici Scientifici Maugeri"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22288","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"ref0","unstructured":"1. Vaporidi K, Akoumianaki E, Telias I, Goligher EC, Brochard L,"},{"key":"ref1","unstructured":"Georgopoulos D. Respiratory Drive in Critically Ill Patients."},{"key":"ref2","unstructured":"Pathophysiology and Clinical Implications. Am J Respir Crit Care"},{"key":"ref3","unstructured":"Med. 2020;201(1):20-32. https:\/\/doi.org\/10.1164\/rccm.201903-"},{"key":"ref4","unstructured":"0596SO"},{"key":"ref5","unstructured":"2. Cill\u00f3niz C, Torres A, Niederman MS. Management of pneumonia"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"in critically ill patients. BMJ. 2021;375:e065871. https:\/\/doi.","DOI":"10.1136\/bmj-2021-065871"},{"key":"ref7","unstructured":"org\/10.1136\/bmj-2021-065871"},{"key":"ref8","unstructured":"3. Hofhuis JG, Spronk PE, van Stel HF, Schrijvers AJ, Rommes JH,"},{"key":"ref9","unstructured":"Bakker J. Experiences of critically ill patients in the ICU. Intensive"},{"key":"ref10","unstructured":"Crit Care Nurs. 2008;24(5):300-313. https:\/\/doi.org\/10.1016\/j."},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"iccn.2008.03.004","DOI":"10.1088\/1126-6708\/2008\/03\/004"},{"key":"ref12","unstructured":"4. Murthy S, Gomersall CD, Fowler RA. Care for Critically Ill Patients"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"With COVID-19. JAMA. 2020;323(15):1499-1500. https:\/\/doi.","DOI":"10.1001\/jama.2020.3633"},{"key":"ref14","unstructured":"org\/10.1001\/jama.2020.3633"},{"key":"ref15","unstructured":"5. Li L, Li R, Wu Z, Yang X, Zhao M, Liu J, et al., Therapeutic strategies"},{"key":"ref16","unstructured":"for critically ill patients with COVID-19. Ann Intensive Care."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"2020;10(1):45. https:\/\/doi.org\/10.1186\/s13613-020-00661-z","DOI":"10.1186\/s13613-020-00661-z"},{"key":"ref18","unstructured":"6. Grasselli G, Scaravilli V, Mangioni D, Scudeller L, Alagna L, Bartoletti"},{"key":"ref19","unstructured":"M, et al., Hospital-Acquired Infections in Critically Ill Patients With"},{"key":"ref20","unstructured":"COVID-19. Chest. 2021;160(2):454-465. https:\/\/doi.org\/10.1016\/j."},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"chest.2021.04.002","DOI":"10.1088\/1475-7516\/2021\/04\/002"},{"key":"ref22","unstructured":"7. Fang Y, Zhou J, Ding X, Ling G, Yu S. Pulmonary fibrosis in critical"},{"key":"ref23","unstructured":"ill patients recovered from COVID-19 pneumonia: Preliminary"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"experience. Am J Emerg Med. 2020;38(10):2134-2138. https:\/\/doi.","DOI":"10.1016\/j.ajem.2020.05.120"},{"key":"ref25","unstructured":"org\/10.1016\/j.ajem.2020.05.120"},{"key":"ref26","unstructured":"8. Kato T, Asakura T, Edwards CE, Dang H, Mikami Y, Okuda K, et al."},{"key":"ref27","unstructured":"Prevalence and Mechanisms of Mucus Accumulation in COVID-19"},{"key":"ref28","unstructured":"Lung Disease. Am J Respir Crit Care Med. 2022;206(11):1336-1352."},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1164\/rccm.202111-2606OC","DOI":"10.1164\/rccm.202111-2606OC"},{"key":"ref30","unstructured":"9. Mohammadi A, Balan I, Yadav S, Matos WF, Kharawala A,"},{"key":"ref31","unstructured":"Gaddam M, et al. Post-COVID-19 Pulmonary Fibrosis. Cureus."},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"2022;14(3):e22770.. https:\/\/doi.org\/10.7759\/cureus.22770","DOI":"10.7759\/cureus.22770"},{"key":"ref33","unstructured":"10. Martinez-Garcia MA, Guan WJ, de-la-Rosa D, Athanazio R, Oscullo"},{"key":"ref34","unstructured":"G, Shi MX, et al. Post-TB bronchiectasis: from pathogenesis to"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"rehabilitation. Int J Tuberc Lung Dis. 2023;27(3):175-181. https:\/\/doi.","DOI":"10.5588\/ijtld.22.0566"},{"key":"ref36","unstructured":"org\/10.5588\/ijtld.22.0566"},{"key":"ref37","unstructured":"11. Ravimohan S, Kornfeld H, Weissman D, Bisson GP. Tuberculosis and"},{"key":"ref38","unstructured":"lung damage: from epidemiology to pathophysiology. Eur Respir Rev."},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"2018;27(147):170077. https:\/\/doi.org\/10.1183\/16000617.0077-2017","DOI":"10.1183\/16000617.0077-2017"},{"key":"ref40","unstructured":"12. Allwood BW, Byrne A, Meghji J, Rachow A, van der Zalm MM,"},{"key":"ref41","unstructured":"Schoch OD. Post-Tuberculosis Lung Disease: Clinical Review of an"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Under-Recognised Global Challenge. Respiration. 2021;100(8):751-","DOI":"10.1159\/000512531"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"763. https:\/\/doi.org\/10.1159\/000512531","DOI":"10.1159\/000512531"},{"key":"ref44","unstructured":"13. Sadowska AM. N-Acetylcysteine mucolysis in the management"},{"key":"ref45","unstructured":"of chronic obstructive pulmonary disease. Ther Adv Respir Dis."},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"2012;6(3):127-135. https:\/\/doi.org\/10.1177\/1753465812437563","DOI":"10.1177\/1753465812437563"},{"key":"ref47","unstructured":"14. Tang W, Zhu D, Wu F, Xu JF, Yang JP, Deng ZP, et al. Intravenous"},{"key":"ref48","unstructured":"N-acetylcysteine in respiratory disease with abnormal mucus"},{"key":"ref49","unstructured":"secretion. Eur Rev Med Pharmacol Sci. 2023;27(11):5119-5127."},{"key":"ref50","unstructured":"https:\/\/doi.org\/10.26355\/eurrev_202306_32628"},{"key":"ref51","unstructured":"15. Zhou N, Yang X, Huang A, Chen Z. The Potential"},{"key":"ref52","unstructured":"Mechanism of N-acetylcysteine in Treating COVID-19. Curr"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Pharm Biotechnol. 2021;22(12):1584-1590. https:\/\/doi.","DOI":"10.2174\/18734316MTEyyNzY6y"},{"key":"ref54","unstructured":"org\/10.2174\/18734316MTEyyNzY6y"},{"key":"ref55","unstructured":"16. Micheletto C, Izquierdo JL, Avdeev SN, Rada Escobar RA, Pacheco"},{"key":"ref56","unstructured":"Gallego MC. N-acetylcysteine as a therapeutic approach to postCOVID-19 pulmonary fibrosis adjunctive treatment. Eur Rev Med"},{"key":"ref57","unstructured":"Pharmacol Sci. 2022;26(13):4872-4880. https:\/\/doi.org\/10.26355\/"},{"key":"ref58","unstructured":"eurrev_202207_29212"},{"key":"ref59","unstructured":"17. De Flora S, Balansky R, La Maestra S. Rationale for the use"},{"key":"ref60","unstructured":"of N-acetylcysteine in both prevention and adjuvant therapy"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"of COVID-19. FASEB J. 2020;34(10):13185-13193. https:\/\/doi.","DOI":"10.1096\/fj.202001807"},{"key":"ref62","unstructured":"org\/10.1096\/fj.202001807"},{"key":"ref63","unstructured":"18. de Alencar JCG, Moreira CL, M\u00fcller AD, Chaves CE, Fukuhara MA,"},{"key":"ref64","unstructured":"da Silva EA, et al. Double-blind, Randomized, Placebo-controlled Trial"},{"key":"ref65","unstructured":"With N-acetylcysteine for Treatment of Severe Acute Respiratory"},{"key":"ref66","unstructured":"Syndrome Caused by Coronavirus Disease 2019 (COVID-19). Clin"},{"key":"ref67","unstructured":"Infect Dis. 2021;72(11):e736-e741. https:\/\/doi.org\/10.1093\/cid\/"},{"key":"ref68","unstructured":"ciaa1443"},{"key":"ref69","unstructured":"19. Jaiswal N, Patel KJ, Saxena S, Nyati P, Maurya S, Shah H. Efficacy"},{"key":"ref70","unstructured":"of N\u2010Acetyl Cysteine in COVID\u201019 Patients: A Randomised Double"},{"key":"ref71","unstructured":"Blind Placebo Control Clinical Trial in Central India. Res J Med Sci."},{"key":"ref72","unstructured":"2023;17:620\u2010625, https:\/\/doi.org\/10.59218\/makrjms.2023.620.625"},{"key":"ref73","unstructured":"20. Teskey G, Cao R, Islamoglu H, Medina A, Prasad C, Prasad R, et"},{"key":"ref74","unstructured":"al. The Synergistic Effects of the Glutathione Precursor, NAC and"},{"key":"ref75","unstructured":"First-Line Antibiotics in the Granulomatous Response Against"},{"key":"ref76","unstructured":"Mycobacterium tuberculosis. Front Immunol. 2018;9:2069. https:\/\/"},{"key":"ref77","unstructured":"doi.org\/10.3389\/fimmu.2018.02069"},{"key":"ref78","unstructured":"21. Yegiazaryan A, Abnousian A, Alexander LJ, Badaoui A, Flaig B,"},{"key":"ref79","unstructured":"Sheren N, et al. Recent Developments in the Understanding of"},{"key":"ref80","unstructured":"Immunity, Pathogenesis and Management of COVID-19. Int J Mol"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"Sci. 2022;23(16):9297. https:\/\/doi.org\/10.3390\/ijms23169297","DOI":"10.3390\/ijms23169297"},{"key":"ref82","unstructured":"22. Wallis RS, Sabi I, Lalashowi J, Bakuli A, Mapamba D, Olomi W, et"},{"key":"ref83","unstructured":"al. Adjunctive N-Acetylcysteine and Lung Function in Pulmonary"},{"key":"ref84","unstructured":"Tuberculosis. NEJM Evid. 2024;3(9):EVIDoa2300332. https:\/\/doi."},{"key":"ref85","unstructured":"23. Mapamba DA, Sabi I, Lalashowi J, Sauli E, Buza J, Olomi W, et al."},{"key":"ref86","unstructured":"N-acetylcysteine modulates markers of oxidation, inflammation and"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"infection in tuberculosis. J Infect. 2025;90(2):106379. https:\/\/doi.","DOI":"10.1016\/j.jinf.2024.106379"},{"key":"ref88","unstructured":"org\/10.1016\/j.jinf.2024.106379"},{"key":"ref89","unstructured":"24. Nasiri MJ, Khoshdel N, Venketaraman V. Glutathione and"},{"key":"ref90","unstructured":"N-acetylcysteine in TB management. Int J Tuberc Lung Dis."},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"2025;29(4):171-177. https:\/\/doi.org\/10.5588\/ijtld.24.0604","DOI":"10.5588\/ijtld.24.0604"},{"key":"ref92","unstructured":"25. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred"},{"key":"ref93","unstructured":"reporting items for systematic reviews and meta-analyses: the"},{"key":"ref94","doi-asserted-by":"crossref","unstructured":"PRISMA statement. PLoS Med. 2009;6(7):e1000097. https:\/\/doi.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"ref95","unstructured":"org\/10.1371\/journal.pmed.1000097"},{"key":"ref96","unstructured":"26. Masoompour SM, Anushiravani A, Tafaroj Norouz A. Evaluation of"},{"key":"ref97","unstructured":"the Effect of Nebulized N-Acetylcysteine on Respiratory Secretions"},{"key":"ref98","unstructured":"in Mechanically Ventilated Patients: Randomized Clinical Trial. Iran J"},{"key":"ref99","unstructured":"Med Sci. 2015;40(4):309-315."},{"key":"ref100","unstructured":"27. Rahimi A, Samimagham H, Hajiabdolrrasouli L, Hassani Azad M,"},{"key":"ref101","unstructured":"Salimi Asl A, et al. Efficacy of N-acetyl Cysteine in Severe COVID-19"},{"key":"ref102","unstructured":"Patients: A Randomized Controlled Phase III Clinical Trial.Jundishapur"},{"key":"ref103","unstructured":"J Nat Pharm Prod.2023;18(1):e129817. https:\/\/doi.org\/10.5812\/"},{"key":"ref104","unstructured":"jjnpp-129817"},{"key":"ref105","unstructured":"28. Gamarra-Morales Y, Herrera-Quintana L, Molina-L\u00f3pez J, V\u00e1zquezLorente H, Machado-Casas JF, Casta\u00f1o-P\u00e9rez J, et al. Response"},{"key":"ref106","unstructured":"to Intravenous N-Acetylcysteine Supplementation in Critically Ill"},{"key":"ref107","doi-asserted-by":"crossref","unstructured":"Patients with COVID-19. Nutrients. 2023;15(9):2235. https:\/\/doi.","DOI":"10.3390\/nu15092235"},{"key":"ref108","unstructured":"org\/10.3390\/nu15092235"},{"key":"ref109","unstructured":"29. Ghorbi M, Rashidi M, Olapour A, Javaherforooshzadeh F,"},{"key":"ref110","unstructured":"Akhondzadeh R. Effect of N-Acetylcysteine on the treatment of"},{"key":"ref111","unstructured":"acute respiratory distress syndrome in mechanically ventilated"},{"key":"ref112","unstructured":"patients admitted to the intensive care unit. Med J Islam Repub Iran."},{"key":"ref113","doi-asserted-by":"crossref","unstructured":"2021;35:87. https:\/\/doi.org\/10.47176\/mjiri.35.87","DOI":"10.47176\/mjiri.35.87"},{"key":"ref114","unstructured":"30. Kanne JP, Little BP, Schulte JJ, Haramati A, Haramati LB. Longterm Lung Abnormalities Associated with COVID-19 Pneumonia."},{"key":"ref115","unstructured":"Radiology. 2023;306(2):e221806. https:\/\/doi.org\/10.1148\/"},{"key":"ref116","unstructured":"radiol.221806"},{"key":"ref117","unstructured":"31. Wang F, Kream RM, Stefano GB. Long-Term Respiratory"},{"key":"ref118","unstructured":"and Neurological Sequelae of COVID-19. Med Sci Monit."},{"key":"ref119","doi-asserted-by":"crossref","unstructured":"2020;26:e928996. https:\/\/doi.org\/10.12659\/MSM.928996","DOI":"10.12659\/MSM.928996"},{"key":"ref120","unstructured":"32. George PM, Barratt SL, Condliffe R, Desai SR, Devaraj A,"},{"key":"ref121","unstructured":"Forrest I, et al. Respiratory follow-up of patients with COVID-19"},{"key":"ref122","doi-asserted-by":"crossref","unstructured":"pneumonia. Thorax. 2020;75(11):1009-1016. https:\/\/doi.org\/10.1136\/","DOI":"10.1136\/thoraxjnl-2020-215314"},{"key":"ref123","unstructured":"thoraxjnl-2020-215314"},{"key":"ref124","unstructured":"33. Seo W, Kim HW, Kim JS, Min J. Long term management of"},{"key":"ref125","unstructured":"people with post-tuberculosis lung disease. Korean J Intern Med."},{"key":"ref126","doi-asserted-by":"crossref","unstructured":"2024;39(1):7-24. https:\/\/doi.org\/10.3904\/kjim.2023.395","DOI":"10.3904\/kjim.2023.395"},{"key":"ref127","unstructured":"34. Thomson H, Baines N, Huisamen T, Koegelenberg CFN, Irusen EM,"},{"key":"ref128","unstructured":"Mapahla L, et al. A new understanding of clinical patterns in post-TB"},{"key":"ref129","doi-asserted-by":"crossref","unstructured":"lung disease. Int J Tuberc Lung Dis. 2024;28(3):115-121. https:\/\/doi.","DOI":"10.5588\/ijtld.23.0327"},{"key":"ref130","unstructured":"org\/10.5588\/ijtld.23.0327"},{"key":"ref131","unstructured":"35. Santus P, Signorello JC, Danzo F, Lazzaroni G, Saad M, Radovanovic"},{"key":"ref132","unstructured":"D. Anti-Inflammatory and Anti-Oxidant Properties of N-Acetylcysteine:"},{"key":"ref133","doi-asserted-by":"crossref","unstructured":"A Fresh Perspective. J Clin Med. 2024;13(14):4127. https:\/\/doi.","DOI":"10.3390\/jcm13144127"},{"key":"ref134","unstructured":"org\/10.3390\/jcm13144127"},{"key":"ref135","unstructured":"36. Aldini G, Altomare A, Baron G, Vistoli G, Carini M, Borsani L, et al."},{"key":"ref136","unstructured":"N-Acetylcysteine as an antioxidant and disulphide breaking agent: the"},{"key":"ref137","doi-asserted-by":"crossref","unstructured":"reasons why. Free Radic Res. 2018;52(7):751-762. https:\/\/doi.org\/10","DOI":"10.1080\/10715762.2018.1468564"},{"key":"ref138","unstructured":".1080\/10715762.2018.1468564"},{"key":"ref139","unstructured":"37. Sharafkhah M, Abdolrazaghnejad A, Zarinfar N, Mohammadbeigi"},{"key":"ref140","unstructured":"A, Massoudifar A, Abaszadeh S. Safety and efficacy of N-acetylcysteine for prophylaxis of ventilator-associated pneumonia: a"},{"key":"ref141","unstructured":"randomized, double blind, placebo-controlled clinical trial. Med Gas"},{"key":"ref142","doi-asserted-by":"crossref","unstructured":"Res. 2018;8(1):19-23. https:\/\/doi.org\/10.4103\/2045-9912.229599","DOI":"10.4103\/2045-9912.229599"}],"container-title":["Respiratory Research &amp; Clinical Practice"],"original-title":[],"link":[{"URL":"https:\/\/www.ithenticate.com\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T19:55:12Z","timestamp":1774295712000},"score":1,"resource":{"primary":{"URL":"https:\/\/rrcpjournal.org\/article\/clinical-effects-of-n-acetylcysteine-in-icu-patients-with-respiratory-disease-a-systematic-review-and-meta-analysis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":143,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20250438","relation":{},"ISSN":["3086-3910"],"issn-type":[{"value":"3086-3910","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"article-number":"2025-0438"}}